Alirocumab (anti-PCSK9)Alirocumab (anti-PCSK9)
Move your mouse over image or click to enlarge

Alirocumab (anti-PCSK9)

Alirocumab (anti-PCSK9) works by inhibiting the PCSK9 protein, which binds to the low-density lipoprotein receptor (LDLR) and causes receptor degradation, removing less LDL cholesterol from the circulation.
Cat# Size Price Qty Buy
A2047-1mg*25 1mg*25
£2,432.00
A2047-1mg*5 1mg*5
£800.00
A2047-1mg 1mg
£243.00

Additional Information

Property Value or Rating
Manufacturer Selleck Chemicals LLC
Manufacturer Cat# A2047

Related Documents